Literature DB >> 17073223

Cost effectiveness analysis of smoking cessation interventions.

James Shearer1, Marian Shanahan.   

Abstract

OBJECTIVE: To identify which smoking cessation interventions provide the most efficient use of health care resources at a population level.
METHODS: Effectiveness data were obtained from a review of the international literature. Costs and effects of smoking cessation interventions were estimated from the perspective of the Australian Government. Treatment costs and effects were modelled using incremental cost-effectiveness ratios. Assumptions regarding effectiveness, resource use and costs were tested by sensitivity analysis.
RESULTS: From the population perspective, telephone counselling appeared to be the most cost-effective intervention. Adding proactive forms of telephone counselling increased the effectiveness of pharmacotherapies at a low incremental cost and, therefore, this could be a highly cost-effective strategy. Bupropion appeared to be more cost effective than nicotine replacement therapy (NRT). Combined bupropion and NRT did not appear to be cost effective.
CONCLUSIONS: General practitioners should be encouraged to refer patients to telephone quit lines and if prescribing pharmacotherapy consider the addition of telephone counselling. IMPLICATIONS: The results support greater investment in proactive forms of telephone counselling and more formal integration of pharmacotherapies with proactive telephone counselling services as cost-effective strategies for reducing population-level smoking rates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17073223     DOI: 10.1111/j.1467-842x.2006.tb00458.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  13 in total

1.  Current Status and Future Prospects of Clinical Psychology: Toward a Scientifically Principled Approach to Mental and Behavioral Health Care.

Authors:  Timothy B Baker; Richard M McFall; Varda Shoham
Journal:  Psychol Sci Public Interest       Date:  2008-11-01

2.  Can a Computer-Based Prescription of Free Medication Increase Smoking Cessation Rates Efficiently?

Authors:  Banu Salepci; Ali Fidan; Benan Çağlayan; Elif Torun Parmaksız; Nesrin Kıral; Sevda Şener Cömert; Gülten Aktin Güngör; Egehan Salepci
Journal:  Turk Thorac J       Date:  2015-12-14

Review 3.  Varenicline: a novel pharmacotherapy for smoking cessation.

Authors:  Carlos Jiménez-Ruiz; Ivan Berlin; Thomas Hering
Journal:  Drugs       Date:  2009-07-09       Impact factor: 9.546

4.  Evaluation of a student-run smoking cessation clinic for a medically underserved population.

Authors:  Lindsay E Lough; Jon O Ebbert; Thomas G McLeod
Journal:  BMC Res Notes       Date:  2011-03-08

5.  Within a smoking-cessation program, what impact does genetic information on lung cancer need to have to demonstrate cost-effectiveness?

Authors:  Louisa G Gordon; Nicholas G Hirst; Robert P Young; Paul M Brown
Journal:  Cost Eff Resour Alloc       Date:  2010-09-16

6.  Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking.

Authors:  Natalie Walker; Colin Howe; Chris Bullen; Hayden McRobbie; Marewa Glover; Varsha Parag; Jonathan Williman; Reon Veale; Vili Nosa; Joanne Barnes
Journal:  BMC Public Health       Date:  2011-11-21       Impact factor: 3.295

7.  Smoking cessation: an economic analysis and review of varenicline.

Authors:  Michele A Faulkner
Journal:  Clinicoecon Outcomes Res       Date:  2009-06-24

8.  Targeted versus universal prevention. a resource allocation model to prioritize cardiovascular prevention.

Authors:  Talitha L Feenstra; Pieter M van Baal; Monique O Jacobs-van der Bruggen; Rudolf T Hoogenveen; Geert-Jan Kommer; Caroline A Baan
Journal:  Cost Eff Resour Alloc       Date:  2011-10-06

Review 9.  New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?

Authors:  Emma Beard; Lion Shahab; Damian M Cummings; Susan Michie; Robert West
Journal:  CNS Drugs       Date:  2016-10       Impact factor: 5.749

10.  Current and emerging pharmacotherapeutic options for smoking cessation.

Authors:  Kristin V Carson; Malcolm P Brinn; Thomas A Robertson; Rachada To-A-Nan; Adrian J Esterman; Matthew Peters; Brian J Smith
Journal:  Subst Abuse       Date:  2013-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.